Search Results - "Burger, D.M."

Time-resolved neutron/gamma-ray data acquisition for in situ subsurface planetary geochemistry

Authors: Bodnarik, J.G. Burger, D.M. Burger, A. et al.

Source: Nuclear Instruments & Methods in Physics Research Section A. Apr2013, Vol. 707, p135-142. 8p.

Subjects: Neutrons, Gamma rays, Data acquisition systems, Geochemistry, United States. National Aeronautics & Space Administration, Goddard Institute for Space Studies

Geographic Terms: United States

Simultaneous determination of the azoles voriconazole, posaconazole, isavuconazole, itraconazole and its metabolite hydroxy-itraconazole in human plasma by reversed phase ultra-performance liquid chromatography with ultraviolet detection

Authors: Verweij-van Wissen, C.P.W.G.M. Burger, D.M. Verweij, P.E. et al.

Source: Journal of Chromatography B: Analytical Technologies in the Biomedical & Life Sciences. Mar2012, Vol. 887-888, p79-84. 6p.

Subjects: Azoles, High performance liquid chromatography, Blood plasma, Ultraviolet detectors, Liquid-liquid extraction, Metabolites, Quantitative chemical analysis, Drug monitoring, Pharmacokinetics

Determination of Emtricitabine in Human Plasma using HPLC with Fluorometric Detection.

Authors: Droste, J.A. H. Aarnoutse, R.E. Burger, D.M.

Source: Journal of Liquid Chromatography & Related Technologies. 2007, Vol. 30 Issue 18, p2769-2778. 10p. 4 Charts, 1 Graph.

Drug-drug interactions between direct oral anticoagulants and anticancer drugs: A single center daily practice evaluation of the occurrence, prescriber response, and subsequent thrombotic and bleeding complications in the Netherlands.

Authors: Appelman, E.M. Martens, E.S.L. Burger, D.M. et al.

Source: Thrombosis Research. Jan2025, Vol. 245, pN.PAG-N.PAG. 1p.

Simultaneous determination of the HIV nucleoside analogue reverse transcriptase inhibitors lamivudine, didanosine, stavudine, zidovudine and abacavir in human plasma by reversed phase high performance liquid chromatography

Authors: Verweij-van Wissen, C.P.W.G.M. Aarnoutse, R.E. Burger, D.M.

Source: Journal of Chromatography B: Analytical Technologies in the Biomedical & Life Sciences. Feb2005, Vol. 816 Issue 1/2, p121-129. 9p.

Subjects: High performance liquid chromatography, Solid-phase analysis, Ultraviolet radiation, Nucleosides, Blood plasma

The effect of cholecalciferol supplementation on vitamin D levels and insulin sensitivity is dose related in vitamin D-deficient HIV-1-infected patients.

Authors: van den Bout-van den Beukel, C.J.P. van den Bos, M. Oyen, W.J.G. et al.

Source: HIV Medicine. Oct2008, Vol. 9 Issue 9, p771-779. 9p. 1 Diagram, 4 Charts, 1 Graph.

Quantification of dolutegravir, bictegravir, raltegravir and doravirine in human breastmilk with UPLC-MS/MS.

Authors: L.C., van der Wekken - Pas E.W.J., van Ewijk - Beneken Kolmer te Brake, L.H.M. et al.

Source: Journal of Chromatography B: Analytical Technologies in the Biomedical & Life Sciences. Oct2025, Vol. 1264, pN.PAG-N.PAG. 1p.

Cumulative pemetrexed dose increases the risk of nephrotoxicity.

Authors: de Rouw, N. Boosman, R.J. van de Bruinhorst, H. et al.

Source: Lung Cancer (01695002). Aug2020, Vol. 146, p30-35. 6p.

Decreased tacrolimus plasma concentrations during HCV therapy: a drug–drug interaction or is there an alternative explanation?

Authors: Smolders, E.J. Pape, S. de Kanter, C.T.M.M. et al.

Source: International Journal of Antimicrobial Agents. Mar2017, Vol. 49 Issue 3, p379-382. 4p.

Pharmacokinetically-guided dosing of pemetrexed in a patient with renal impairment and a patient requiring hemodialysis.

Authors: de Rouw, N. Croes, S. Posthuma, R. et al.

Source: Lung Cancer (01695002). Apr2019, Vol. 130, p156-158. 3p.

Development, validation and clinical implementation of a UPLC-MS/MS bioanalytical method for simultaneous quantification of cabotegravir and rilpivirine E-isomer in human plasma.

Authors: Bevers, L.A.H. van Ewijk – Beneken Kolmer, E.W.J. Te Brake, H.M.L. et al.

Source: Journal of Pharmaceutical & Biomedical Analysis. Jan2024, Vol. 238, pN.PAG-N.PAG. 1p.

Effect of efavirenz treatment on the pharmacokinetics of nelfinavir boosted by ritonavir in healthy volunteers.

Authors: la Porte, C.J.L. de Graaff-Teulen, M.J.A. Colbers, E.P.H. et al.

Source: British Journal of Clinical Pharmacology. Dec2004, Vol. 58 Issue 6, p632-640. 9p.

More gastro-intestinal adverse events in non-ICU hospitalised COVID-19 patients treated with chloroquine versus hydroxychloroquine.

Authors: Verheijen, S. van Luin, M. Brüggemann, R.J. et al.

Source: International Journal of Infectious Diseases. Feb2021, Vol. 103, p402-403. 2p.

Exposure and virologic outcomes of dolutegravir combined with ritonavir boosted darunavir in treatment-naïve individuals enrolled in the Netherlands Cohort Study on Acute HIV infection (NOVA).

Authors: Prins, H.A.B. Zino, L. Svensson, E.M. et al.

Source: International Journal of Antimicrobial Agents. Jan2023, Vol. 61 Issue 1, pN.PAG-N.PAG. 1p.

Chloroquine for treatment of COVID-19 results in subtherapeutic exposure and prolonged QTc intervals.

Authors: Brüggemann, R.J. Moes, D.J.A.R. van Rhee, K.P. et al.

Source: International Journal of Antimicrobial Agents. Mar2021, Vol. 57 Issue 3, pN.PAG-N.PAG. 1p.

Effective treatment of hepatitis C virus infection with sofosbuvir and daclatasvir 90 mg in a patient with severe epilepsy on oxcarbazepine.

Authors: Smolders, E.J. de Kanter, C.T.M.M. van 't Veer, N. et al.

Source: International Journal of Antimicrobial Agents. Sep2016, Vol. 48 Issue 3, p347-348. 2p.

P1344 : Determining the hepatic cyst penetration of cefazolin and factors affecting penetration, an explorative study.

Authors: Lantinga, M.A. Wijnands, T.F. te Morsche, R.H. et al.

Source: Journal of Hepatology. Apr2015 Supplement 2, Vol. 62, pS861-S861. 1p.

244 RIBAVIRIN-RATHER THAN PEG-INTERFERON-RELATED FACTORS ARE PREDICTING NON-RESPONSE TO ANTIVIRAL THERAPY IN NAIVE CHRONIC HEPATITIS C PATIENTS

Authors: van Vlerken, L.G. Huisman, E.J. van Soest, H. et al.

Source: Journal of Hepatology. Apr2010 Supplement 1, Vol. 52, pS103-S103. 1p.

243 ENDOGENOUS ERYTHROPOIETIN RESPONSE AND PREDICTIVE FACTORS FOR ANEMIA DURING TREATMENT WITH PEG-INTERFERON ALFA-2B AND RIBAVIRIN IN CHRONIC HEPATITIS C PATIENTS

Authors: van Vlerken, L.G. van Soest, H. Janssen, M.P. et al.

Source: Journal of Hepatology. Apr2010 Supplement 1, Vol. 52, pS103-S103. 1p.